4//SEC Filing
ALTMAN MICHAEL SETH 4
Accession 0000899243-23-016073
CIK 0001808805other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 8:52 PM ET
Size
5.6 KB
Accession
0000899243-23-016073
Insider Transaction Report
Form 4
ALTMAN MICHAEL SETH
DirectorChief Financial Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2023-06-15+45,000→ 45,000 totalExercise: $3.97Exp: 2033-06-15→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date.
Documents
Issuer
Nautilus Biotechnology, Inc.
CIK 0001808805
Entity typeother
Related Parties
1- filerCIK 0001746738
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 8:52 PM ET
- Size
- 5.6 KB